Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
Glioblastoma multiforme (GBM) is rare and fatal glioma with limited treatment options. Treatments provide minimal improvement in prognosis and only 6.8% of GBM patients have a life expectancy greater than five years. Surgical resection of this malignant glioma is difficult due to its highly invasive...
Main Authors: | Daniel E. Morales, Shaker Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-05-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022008052 |
Similar Items
-
Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas
by: Maria Caffo, et al.
Published: (2018-01-01) -
Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications
by: Buddolla Anantha Lakshmi, et al.
Published: (2022-01-01) -
Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
by: Oxana Semyachkina-Glushkovskaya, et al.
Published: (2022-12-01) -
Nanoparticle-Based Treatment in Glioblastoma
by: Diogo Roque, et al.
Published: (2023-08-01) -
Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
by: Lin Tang, et al.
Published: (2022-05-01)